Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
43.45
-0.05 (-0.11%)
Official Closing Price
Updated: 7:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,045,663
Open
43.50
Bid (Size)
42.87 (1)
Ask (Size)
43.60 (1)
Prev. Close
43.50
Today's Range
43.17 - 43.64
52wk Range
33.33 - 43.84
Shares Outstanding
5,385,189,617
Dividend Yield
3.32%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
May 02, 2024
Moderna is forming its first base in over a year. Could shares top a buy point on the company's sales beat?
Via
Investor's Business Daily
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
May 01, 2024
While these sleeper stocks to buy don’t attract the spotlight, the lack of attention makes these ideas even more enticing.
Via
InvestorPlace
Performance
YTD
+15.84%
+15.84%
1 Month
+6.36%
+6.36%
3 Month
+4.52%
+4.52%
6 Month
+24.89%
+24.89%
1 Year
+18.17%
+18.17%
More News
Read More
GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
May 01, 2024
Via
Benzinga
Forget the Fed. These 3 Stocks Will Soar No Matter What
April 29, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Peering Into GSK's Recent Short Interest
March 26, 2024
Via
Benzinga
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
May 01, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
April 26, 2024
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
What's Going On With Pfizer Stock On Thursday?
April 25, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
April 19, 2024
Via
Benzinga
Topics
Brexit
Exposures
Brexit
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
April 18, 2024
Via
Benzinga
GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years
April 17, 2024
Via
Benzinga
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
April 11, 2024
Via
Benzinga
Down 75%. Is Agenus Stock a Buy on the Dip?
April 08, 2024
Via
The Motley Fool
CureVac, GS Partner Release Data On Influenza Vaccine Study
April 04, 2024
Via
Benzinga
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
April 04, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
April 03, 2024
Via
MarketBeat
Exposures
Product Safety
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
April 03, 2024
Via
The Motley Fool
Russell 2000 Index Best And Worst Performing Stocks Of 2024
April 02, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
March 24, 2024
Via
The Motley Fool
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
March 21, 2024
Via
Benzinga
GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer
March 18, 2024
Via
Benzinga
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
March 18, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.